Stock NYMXF NYMOX PHARMACEUTICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Nymox Pharmaceutical Corporation

Equities

NYMXF

BSP733981026

Market Closed - OTC Markets
Other stock markets
 12:22:55 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.3 USD -6.25% Intraday chart for Nymox Pharmaceutical Corporation 0.00% -49.15%
2023 Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
GL
OTC F-Stocks Holiday Momentum Watchlist (TBRIF, PYRGF, NYMXF, MGDPF)
AQ
Nymox December 27 Message to Shareholders
GL
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
GL
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
GL
Nymox: Q3 Earnings Snapshot
AQ
Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Nymox Pharmaceutical : MANAGEMENT’S DISCUSSION AND ANALYSIS - Form 6-K
PU
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
GL
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
GL
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
GL
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
AQ
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
GL
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
GL
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
GL
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review
GL
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH
GL
Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH
CI
Nymox Reports Completion of $2 Million Private Placement
GL
Nymox Pharmaceutical Corporation announced that it has received $2 million in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NYMXF Stock
  4. News Nymox Pharmaceutical Corporation